44 related articles for article (PubMed ID: 23387388)
21. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
22. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
23. The tumor necrosis factor superfamily members TWEAK, TNFSF15 and fibroblast growth factor-inducible protein 14 are upregulated in proliferative diabetic retinopathy.
Abu El-Asrar AM; De Hertogh G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mohammad G; Opdenakker G; Geboes K
Ophthalmic Res; 2015; 53(3):122-30. PubMed ID: 25676319
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
25. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Struyf S; Mohammad G; Gouwy M; Rytinx P; Siddiquei MM; Hernández C; Alam K; Mousa A; De Hertogh G; Opdenakker G; Simó R
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3189-3201. PubMed ID: 28654984
[TBL] [Abstract][Full Text] [Related]
26. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.
Simó R; Carrasco E; García-Ramírez M; Hernández C
Curr Diabetes Rev; 2006 Feb; 2(1):71-98. PubMed ID: 18220619
[TBL] [Abstract][Full Text] [Related]
27. The role of extracellular matrix in retinal vascular development and preretinal neovascularization.
Bishop PN
Exp Eye Res; 2015 Apr; 133():30-6. PubMed ID: 25819452
[TBL] [Abstract][Full Text] [Related]
28. [Correlation with histological findings and visual prognosis in epiretinal membrane of human diabetic retinopathy].
Kase S
Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):998-1006. PubMed ID: 22171505
[TBL] [Abstract][Full Text] [Related]
29. Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.
Masli S; Sheibani N; Cursiefen C; Zieske J
Curr Eye Res; 2014 Aug; 39(8):759-74. PubMed ID: 24559320
[TBL] [Abstract][Full Text] [Related]
30. The Roles of Thrombospondins in Hemorrhagic Stroke.
Wu X; Luo X; Zhu Q; Zhang J; Liu Y; Luo H; Cheng Y; Xie Z
Biomed Res Int; 2017; 2017():8403184. PubMed ID: 29214179
[TBL] [Abstract][Full Text] [Related]
31. Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.
Rusnati M; Urbinati C; Bonifacio S; Presta M; Taraboletti G
Pharmaceuticals (Basel); 2010 Apr; 3(4):1241-1278. PubMed ID: 27713299
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondins and tumor angiogenesis.
de Fraipont F; Nicholson AC; Feige JJ; Van Meir EG
Trends Mol Med; 2001 Sep; 7(9):401-7. PubMed ID: 11530335
[TBL] [Abstract][Full Text] [Related]
33. Endothelial Cell Behavior Is Determined by Receptor Clustering Induced by Thrombospondin-1.
Morandi V; Petrik J; Lawler J
Front Cell Dev Biol; 2021; 9():664696. PubMed ID: 33869231
[TBL] [Abstract][Full Text] [Related]
34. Original insights on thrombospondin-1-related antireceptor strategies in cancer.
Jeanne A; Schneider C; Martiny L; Dedieu S
Front Pharmacol; 2015; 6():252. PubMed ID: 26578962
[TBL] [Abstract][Full Text] [Related]
35. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
